Topic
fda-approvals
6 stories related to this topic, newest first.
benzinga.comscience1 day ago
Eli Lilly Shares Ajax Acquisition Data Showing Myelofibrosis Drug Candidate
Eli Lilly released initial clinical results from its acquisition of Ajax Therapeutics on June 15, 2026. The data position the program as a potential competitor to existing myelofibrosis treatments.
manilatimes.netscience34 days ago
Bristol Myers Squibb Partners With Hengrui Pharma on Early-Stage Programs
Bristol Myers Squibb announced a partnership with Hengrui Pharma covering more than a dozen early-stage programs. The agreement is the latest instance of a global pharmaceutical company seeking medicines from China. Separately, Viiv lost an HIV treatment patent case while other c…
foxnews.comscience43 days ago
Trump Administration Eases Federal Restrictions on Medical Marijuana Amid Widespread Use for Pain Management
President Trump has recently eased restrictions on medical marijuana, which millions of Americans use to treat chronic pain and other conditions. The Food and Drug Administration has approved a limited number of cannabis-based drugs for specific ailments. Experts note potential b…
New York Postfinance51 days ago
FDA Greenlights First U.S. Trial of Ibogaine Derivative for Treating Alcohol Use Disorder
The Food and Drug Administration has greenlit the first human clinical trial of an ibogaine derivative in the United States to test its potential as a treatment for alcohol use disorder. This follows President Trump's executive order to fast-track psychedelic research. The agency…
Statscience54 days ago
FDA Approves Addyi for Women Under 65
The Food and Drug Administration has expanded the use of Addyi, a drug treating low libido, to all women under 65. Sprout Pharmaceuticals is promoting discounted telehealth consultations for prescriptions via Prescribery. Health experts note potential concerns with pharmaceutical…
Substrate placeholder — needs reviewscience54 days ago
Revolution Medicines Presents Strong KRAS Drug Data and Preclinical Compound Insights
Revolution Medicines shared clinical trial success for its pancreatic cancer therapy last week and preclinical data on a new compound yesterday. The company also presented strong results for its KRAS drug at the AACR meeting on April 21, 2026. Additional biotech developments incl…
ST